+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infantile Spasms Therapeutics Market - Global Forecast 2025-2030- Product Image
Infantile Spasms Therapeutics Market - Global Forecast 2025-2030- Product Image
Sale

Infantile Spasms Therapeutics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904865
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Infantile Spasms Therapeutics Market is undergoing significant transformation, with clinical advancements, innovative treatments, and shifting global dynamics creating new opportunities and challenges for industry leaders. This report delivers a focused, actionable analysis designed to inform strategic decisions in this evolving field.

Market Snapshot: Infantile Spasms Therapeutics Market Growth Trajectory

The Infantile Spasms Therapeutics Market grew from USD 406.01 million in 2024 to USD 432.78 million in 2025. Sustained momentum is expected, fueled by continued investment in novel therapeutics and advancements in clinical practice, leading to a CAGR of 6.47% and reaching USD 591.63 million by 2030. This positive trajectory reflects increasing demand for precise, patient-centered interventions and the ongoing evolution of therapeutic frameworks worldwide.

Scope & Segmentation of the Infantile Spasms Therapeutics Market

This report comprehensively analyzes the breadth of the infantile spasms therapeutics ecosystem, spanning drugs, supply networks, and delivery models across major global markets.

  • Therapeutic Classes: Anti-epileptic drugs (focusing on vigabatrin), Hormonal therapies (including adrenocorticotropic hormone and corticosteroids).
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies.
  • Administration Routes: Injectables (intramuscular, intravenous), Orals (solution, tablet).
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, with specific state granularity in the US), Europe, Middle East, and Africa (major economies and healthcare hubs), Asia-Pacific (China, India, Japan, Australia, and leading emerging healthcare markets).
  • Technologies & Innovations: Advances in diagnostic imaging, genetic profiling, biomarker identification, as well as platform technologies like allosteric modulators and gene therapy constructs.
  • Key Industry Participants: Profiled companies include Mallinckrodt plc, UCB Pharma SA, Teva Pharmaceutical Industries Ltd., BIOSPACE INC., ORPHELIA Pharma, Amneal Pharmaceuticals LLC, CIPLA LIMITED, Zydus Group, Marinus Pharmaceuticals Inc., and Ovid Therapeutics Inc.

Key Takeaways for Senior Decision-Makers

  • Ongoing innovation is reshaping clinical guidelines and expanding therapeutic options, leading to greater differentiation in treatment approaches and outcomes.
  • Precision medicine, leveraging genomic and proteomic insights, is increasingly dictating therapeutic selection and improving seizure management strategies.
  • Cross-sector collaborations—among academic consortia, biotech firms, and manufacturers—are accelerating early-stage drug development and translating research into promising clinical candidates.
  • Distribution strategies must address changing prescribing trends, with rising emphasis on outpatient care and the growing role of digital and telehealth-enabled delivery channels.
  • Manufacturers and payers are required to balance the cost of specialized injectable therapies versus the convenience and broader access provided by oral formulations.
  • Pioneering companies are building competitive advantage by complementing product portfolios with patient support services, data-driven monitoring tools, and education for caregivers and clinicians in specialized pediatric neurology.

Tariff Impact: Navigating US Trade Policy Adjustments

Recent US tariff revisions are exerting direct pressure on the infantile spasms therapeutics supply chain, resulting in higher production costs for imported pharmaceutical ingredients and excipients. Companies are diversifying supplier bases, localizing select manufacturing activities, and leveraging strategic stockpiling to safeguard continuity of care. With regulatory compliance complexity and evolving pricing strategies, proactive alignment among procurement, regulatory, and commercial teams has become critical to mitigating risk and managing volatility, while ensuring affordable, uninterrupted patient access across distribution channels.

Methodology & Data Sources

This research applies a dual-layered methodology: primary insights were collected through targeted interviews with pediatric neurologists, clinical pharmacologists, KOLs, and supply chain experts, while secondary research included systematic reviews of academic literature, regulatory filings, and market intelligence reports. Triangulation and quality audits ensure data integrity and relevance for strategic planning.

Why This Report Matters

  • Enables senior leaders to identify and prioritize emerging opportunities and address supply chain challenges across key therapeutic segments.
  • Supports the development of evidence-based, regionally tailored strategies aligned with evolving regulatory landscapes and patient needs for rare pediatric neurological disorders.
  • Equips industry stakeholders with actionable intelligence to facilitate investment decisions, anticipate technological disruption, and optimize market access strategies.

Conclusion

The Infantile Spasms Therapeutics Market is positioned for advanced growth, driven by clinical breakthroughs, robust collaboration, and adaptive business models. Strategic, data-driven approaches will be essential in achieving both improved patient outcomes and commercial success within this dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in genetic biomarker-guided therapeutic strategies for infantile spasms management
5.2. Emergence of synthetic ACTH analogues with enhanced safety profiles in infantile spasms treatment
5.3. Expansion of patient access and early diagnosis initiatives in emerging markets for infantile spasms
5.4. Regulatory fast-track approvals for repurposed neuroinflammatory modulators in IS treatment
5.5. Integration of telehealth monitoring and AI-enabled seizure detection for infantile spasms management
5.6. Clinical trial breakthroughs in cannabidiol-based adjunct therapies for refractory infantile spasms
5.7. Strategic partnerships between biotech firms and academic centers for precision infantile spasms medicine
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Infantile Spasms Therapeutics Market, by Therapeutic Class
8.1. Introduction
8.2. Anti-Epileptic Drugs
8.2.1. Vigabatrin
8.3. Hormonal Therapies
8.3.1. Adrenocorticotropic Hormone
8.3.2. Corticosteroids
9. Infantile Spasms Therapeutics Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Infantile Spasms Therapeutics Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Intramuscular
10.2.2. Intravenous
10.3. Oral
10.3.1. Solution
10.3.2. Tablet
11. Americas Infantile Spasms Therapeutics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Infantile Spasms Therapeutics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Infantile Spasms Therapeutics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Mallinckrodt plc
14.3.2. UCB Pharma SA
14.3.3. Teva Pharmaceutical Industries Ltd.
14.3.4. BIOSPACE, INC.
14.3.5. ORPHELIA Pharma
14.3.6. Amneal Pharmaceuticals LLC
14.3.7. CIPLA LIMITED
14.3.8. Zydus Group
14.3.9. Marinus Pharmaceuticals, Inc.
14.3.10. Ovid Therapeutics, Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. INFANTILE SPASMS THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. INFANTILE SPASMS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. INFANTILE SPASMS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. INFANTILE SPASMS THERAPEUTICS MARKET: RESEARCHAI
FIGURE 22. INFANTILE SPASMS THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 23. INFANTILE SPASMS THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 24. INFANTILE SPASMS THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INFANTILE SPASMS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY VIGABATRIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY VIGABATRIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ADRENOCORTICOTROPIC HORMONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ADRENOCORTICOTROPIC HORMONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 84. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 85. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 86. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 87. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 88. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 89. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 94. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 95. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 96. CANADA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 97. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 98. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 99. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 100. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 101. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 102. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 103. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 169. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 170. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 171. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 172. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 173. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 174. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 175. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 180. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 182. GERMANY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 183. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 184. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 185. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 186. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 187. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 188. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 189. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 194. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 196. FRANCE INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 211. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 212. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 213. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 214. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 215. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 216. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 217. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 222. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 223. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 224. ITALY INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 225. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 226. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 227. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 228. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 229. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 230. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 231. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 236. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 238. SPAIN INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 254. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 268. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 281. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 282. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 283. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 284. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 285. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 286. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 287. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 292. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 293. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 294. DENMARK INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 295. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 296. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY ANTI-EPILEPTIC DRUGS, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS INFANTILE SPASMS THERAPEUTICS MARKET SIZE, BY HORMONAL THERAPIES, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

  • Mallinckrodt plc
  • UCB Pharma SA
  • Teva Pharmaceutical Industries Ltd.
  • BIOSPACE, INC.
  • ORPHELIA Pharma
  • Amneal Pharmaceuticals LLC
  • CIPLA LIMITED
  • Zydus Group
  • Marinus Pharmaceuticals, Inc.
  • Ovid Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 432.78 Million
Forecasted Market Value ( USD ) by 2030 $ 591.63 Million
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Infantile Spasms Therapeutics Market by Therapeutic Class, Drug Type, Dosage, Route of Administration, Distribution Channel, End User, and Region 2025-2033 - Product Image

Infantile Spasms Therapeutics Market by Therapeutic Class, Drug Type, Dosage, Route of Administration, Distribution Channel, End User, and Region 2025-2033

  • Report
  • 128 Pages
  • Global
From
Infantile Spasm Therapeutics - Global Strategic Business Report - Product Image

Infantile Spasm Therapeutics - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Infantile Spasms Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Infantile Spasms Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Infantile Spasm - Pipeline Insight, 2025 - Product Image

Infantile Spasm - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Infantile Spasms Therapeutics Market 2025-2029 - Product Image

Infantile Spasms Therapeutics Market 2025-2029

  • Report
  • 201 Pages
  • Global
From

About the Market

Infantile Spasm (IS) is a rare neurological disorder that affects infants and young children. It is characterized by sudden, brief, and repetitive muscle contractions, usually in the form of jerking movements. Treatment for IS typically involves anticonvulsant drugs, such as vigabatrin, topiramate, and adrenocorticotropic hormone (ACTH). These drugs are used to reduce the frequency and severity of spasms, as well as to prevent further seizures. The Infantile Spasm Drug market is a subset of the Central Nervous System Drugs market. It is a small but growing market, driven by the increasing prevalence of IS and the need for effective treatments. The market is highly competitive, with a number of companies offering various drugs for the treatment of IS. Some of the major companies in the Infantile Spasm Drug market include Pfizer, Novartis, Sanofi, GlaxoSmithKline, and Merck. These companies offer a range of drugs for the treatment of IS, including vigabatrin, topiramate, and ACTH. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.